Steve Miller, Chief Op. & Scientific Officer at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 200,000 shares at $20.59 ($4.1M) on 2024-08-20, disclosed to the SEC on 2024-08-22.
Open-market sale of $4.1M CPRX by Chief Op. & Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.21 | 50,000 | $1.0M | 24.9% |
| 2 | $20.26 | 50,000 | $1.0M | 24.9% |
| 3 | $20.26 | 50,000 | $1.0M | 24.9% |
| 4 | $20.59 | 50,000 | $1.0M | 25.3% |
| Total | $20.33 avg | 200,000 | $4.1M | 100% |
| Filing → |
| CPRX | SELL | 2023-12-07 | $570K | — | Filing → |
| CPRX | SELL | 2022-11-23 | $1.6M | — | Filing → |
| CPRX | SELL | 2022-09-15 | $2.4M | — | Filing → |